NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Jul 24 2025

· Issued by NATCO Pharma Limited

Filed with NSE ·

Natco Pharma Limited has informed the Exchange regarding a press release dated July 24, 2025, titled "NATCO Pharma Limited, API unit in Mekaguda Receives Establishment Inspection Report (EIR) from U.S. FDA".

View Attachment

6ix hasn’t read this filing yet.

NATCO Pharma Limited on 6ix

In the deck

Earlier from NATCO Pharma

Later from NATCO Pharma

All NATCO Pharma news releases